louisakewell, Author at European Medical Journal - Page 36 of 153

EuroPCR 2017 – Congress Highlights

Our full congress review of EuroPCR 2017 is out now in our Interventional Cardiology 5.1 eJournal, and here we present a look at the highlights…

Introducing EMJ Nephrology 5.1

United Kingdom, July 18, 2017: Welcome to the latest edition of EMJ Nephrology. This instalment presents a complete review of the incredibly successful…

Basal Forebrain Atrophy and Elevated Plasmatic Homocysteine Levels in Dementia Patients

Ondrej Lerch, MD from Charles University in Prague, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic discusses a study…

EuroPCR 2017 – Opening Ceremony

Our full congress review of EuroPCR 2017 is out now in our Interventional Cardiology 5.1 eJournal, and here we give you a look into the opening ceremony…

EMJ

ASSIST-FL – Primary Outcome: Interview with Prof. Jurczak

In this interview, Professor Wojciech Jurczak presents and discusses the primary results of ASSIST-FL, the confirmatory, PhIII randomised, double blinded…

RedHill Biopharma Announces Expected Timeline for DSMB Meeting and Provides Update on Enrollment in the RHB-104 Phase III Study for Crohn’s Disease

Tel-Aviv, Israel / Raleigh, NC, USA, 12 July, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”)…

Abu Dhabi Health Show Comes to London

London, UK, 12 July, 2017 – Pri-Med Global is to re-brand its healthcare event into Future Healthcare UK, international exhibition and conference.

Updated St. Gallen International Breast Cancer Guidelines Reinforce Important Role of Genomic Testing in Treatment of Early Breast Cancer

Geneva, Switzerland, 12 July, 2017 – Genomic Health today announced that the 15th St. Gallen International Breast Cancer Conference Expert Panel endorsed…

Agendia’s MammaPrint® Recommended by ASCO Breast Cancer Guideline in Focused Update Based on Landmark MINDACT Trial Data

ASCO recommends MammaPrint® for clinical high risk, hormone receptor-positive, HER2-negative breast cancer, to inform decisions on withholding chemotherapy

Latest Business Conditions Survey Manufacturing Costs and a Challenging NHS Concern UK MedTech

07 July, 2017 – Accessing the NHS and the impact of the weak pound top the list of concerns for Britain’s Medical Technology (MedTech) industry, one year…